Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemo-embolization therapy for hepato-cellular carcinoma

This publication has 12 references indexed in Scilit:

• A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil
  Cancer, 1991
• Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis
  Gastroenterology, 1991
• Co‐production of Interleukin‐1 and Interleukin‐6 in Tumor Cell Lines Elaborating Colony‐stimulating Factors
  Japanese Journal of Cancer Research, 1991
• Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with Cancer
  Annals of Surgery, 1991
• Serum Interleukin 6, C-Reactive Protein and Pancreatic Secretory Trypsin Inhibitor (Psti) as Acute Phase Reactants After Major Thoraco-Abdominal Surgery
  Immunological Investigations, 1990
• Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.
  The Journal of Experimental Medicine, 1988
• Multiple actions of interleukin 6 within a cytokine network
  Immunology Today, 1988
• Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cells
  FEBS Letters, 1987
• Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.
  The Journal of cell biology, 1986
• Interleukin-1 and the Pathogenesis of the Acute-Phase Response
  New England Journal of Medicine, 1984